Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
McKinsey
Dow
Harvard Business School
Merck

Last Updated: August 10, 2022

Details for Patent: 7,700,081


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which drugs does patent 7,700,081 protect, and when does it expire?

Patent 7,700,081 protects CLOBEX and is included in one NDA.

This patent has thirty-two patent family members in twenty-one countries.

Summary for Patent: 7,700,081
Title:Foaming compositions for hair care
Abstract:The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
Inventor(s): Preuilh; Isabelle (Le Cannet, FR), Guise; Anne-Emmanuelle (Rouen, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Galderma S.A. (Cham, CH)
Application Number:11/453,936
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 7,700,081

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs CLOBEX clobetasol propionate SHAMPOO;TOPICAL 021644-001 Feb 5, 2004 AB RX Yes Yes See Plans and Pricing See Plans and Pricing TOPICAL TREATMENT OF SCALP PSORIASIS See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,700,081

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France98 07802Jun 19, 1998

International Family Members for US Patent 7,700,081

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 019321 See Plans and Pricing
Austria 308960 See Plans and Pricing
Austria 444054 See Plans and Pricing
Australia 4151499 See Plans and Pricing
Australia 753735 See Plans and Pricing
Brazil 9911849 See Plans and Pricing
Canada 2333427 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Merck
Moodys
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.